News & Events
[ Topics ]
-
ARCALIS Introduces Novel mRNA Sequence Optimization Technology into mRNA Drug Discovery Services
-
ARCALIS to exhibit at RNA Leaders Europe Congress and Dr. Yanagiya from our business development will deliver a talk at the event
-
Dr.Yoshida from Our Business Development Department to Speak at the 23rd Kansai Medical Research Association Seminar
-
Meiji Seika Pharma Receives Approval for Adding Domestic Manufacturing Sites in Japan for KOSTAIVE®, a Self-amplifying mRNA Vaccine Against COVID-19
-
Meiji Seika Pharma Submits Application to Amend Approval for KOSTAIVE®, a Self-Amplifying mRNA Vaccine against COVID-19, to Include Domestic Manufacturing Site in Japan
-
Dr.Yoshida from ARCALIS will present at the 15th annual meeting of Japanese Association for RNA interference (JARI)
-
Appointment of Vice Chairperson
-
ARCALIS Appoints Qian Ruan to Member of the Board
-
Announcement of Website Renewal
-
PassPort Technologies Commences Collaborative Research with Arcturus Therapeutics
-
Meiji Seika Pharma Receives Manufacturing and Marketing Approval of “ARCT-154”, Self-Amplifying mRNA Vaccine against COVID-19, from MHLW in Japan
-
ARCALIS will be exhibiting at the 11th International mRNA Health Conference.
-
Dr. Drew Weissman, a member of Arcturus Therapeutics’ Scientific Advisory Board, Received 2023 Nobel Prize in Physiology or Medicine
-
Appointment of Vice Chairperson
-
ARCALIS exhibit at the 3rd Annual mRNA-Based Therapeutics Summit
-
Meiji Seika Pharma Submitted an Additional Application for Booster Dose of ARCT-154 in Japan
-
Thursday, June 15, our scientist will give a presentation on a webinar related to mRNA therapeutics, hosted by Roche Diagnostics
-
Meiji Seika Pharma Submitted New Drug Application to Manufacture and Market ARCT-154 in Japan
-
Meiji Seika Pharma Announces that it has entered into an Alliance Agreement for Distribution and Sales of ARCT-154 with CSL Seqirus. Domestic manufacturing system will be promoted by ARCALIS’ mRNA drug manufacturing facility.
-
Meiji Seika Pharma started the Phase III Trial of “ARCT-154”
-
Industry Minister Nishimura visits ARCALIS Minami-soma Plant